Alvotech Files 6-K Report
Ticker: ALVOW · Form: 6-K · Filed: Oct 6, 2025 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Oct 6, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Alvotech filed a routine 6-K, confirming its 20-F reporting status. Nothing new here.
AI Summary
Alvotech, a biopharmaceutical company, filed a Form 6-K on October 6, 2025. This filing is a report of a foreign private issuer and indicates that Alvotech files its annual reports under Form 20-F. The company's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.
Why It Matters
This filing confirms Alvotech's status as a foreign private issuer and its reporting obligations with the SEC, providing transparency for investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new material financial or operational information.
Key Players & Entities
- Alvotech (company) — Registrant
- 001-41421 (company) — SEC File Number
- 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg (company) — Principal executive office address
- Form 20-F (company) — Annual report form
- Form 6-K (company) — Filing type
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes public or is required to disclose in its home country.
What is Alvotech's SEC file number?
Alvotech's SEC file number is 001-41421.
Where is Alvotech's principal executive office located?
Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.
Does Alvotech file its annual reports under Form 20-F?
Yes, the filing indicates that Alvotech files or will file annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed on October 6, 2025.
Filing Stats: 378 words · 2 min read · ~1 pages · Grade level 13.8 · Accepted 2025-10-06 08:00:37
Filing Documents
- f6k_100625.htm (6-K) — 8KB
- exh_991.htm (EX-99.1) — 15KB
- 0001171843-25-006280.txt ( ) — 24KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alvotech (Registrant) Date: October 6, 2025 /s/ Tanya Zharov Tanya Zharov General Counsel